EXAI

Exscientia

1EXAI
GBR
NASDAQ

$4.92

24H

1.13%

Market Cap

643 M

Volume

215.3 K

Supply

130.8 M

Price Chart

About Exscientia - EXAI

Exscientia plc is a pharmaceutical company that utilizes artificial intelligence to design and discover new drugs, aiming to streamline and accelerate the drug development process. It collaborates with various partners from the biotechnology and pharmaceutical industries to work on a diverse range of therapeutic areas.

What are Exscientia's core values and mission statement?

Exscientia plc's core values revolve around innovation, collaboration, and the application of artificial intelligence to accelerate drug discovery and design. Their mission is to discover and design the best possible medicines in the fastest and most efficient way.

Who founded Exscientia and when?

Exscientia plc was founded by Andrew Hopkins in 2012.

Who leads Exscientia?

As of my last update, the CEO of Exscientia plc is Professor Andrew Hopkins.

Where is Exscientia located, and what is its base country?

Exscientia plc is headquartered in Oxford, UK, and its base country is the United Kingdom.

On which exchanges is Exscientia traded?

Exscientia plc is traded on the NASDAQ stock exchange under the ticker symbol EXAI.

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open/Close
Low/High
Volume
Cap

Exscientia (EXAI) Price Live Data

The live price of Exscientia (EXAI) is $4.92, with a trading volume of 215,302 in the last 24 hours. Wrapstocks updates the EXAI price in real-time. Exscientia is up 1.13% in the last 24 hours. The company has a live market cap of $642,990,144.00 and a supply of 130,822,003 EXAI stocks.

Exscientia (EXAI) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 6 hours and 48 minutes.

Exchange
NASDAQ
NASDAQ
NASDAQ Stock Exchange
USA
Opens in
6 hours and 48 minutes
Working Hours
Mon-Fri, 01:30 PM - 09:00 PM
Timezone
GMT+0
Last Updated
01 Nov 2024 07:56 PM